ArriVent BioPharma, Inc. (AVBP) vs Corvus Pharmaceuticals, Inc. (CRVS)
- ArriVent BioPharma, Inc. AVBP 16.66 −0.77%
- Corvus Pharmaceuticals, Inc. CRVS 9.52 −3.35%
ArriVent BioPharma, Inc. and Corvus Pharmaceuticals, Inc. are both Biotechnology companies. ArriVent BioPharma, Inc. and Corvus Pharmaceuticals, Inc. are of similar size ($828.6M and $827.9M). Across the 9 metrics below, Corvus Pharmaceuticals, Inc. leads on 7 and ArriVent BioPharma, Inc. on 2.
Valuation
Profitability
| Metric | AVBP | CRVS | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (53.10%) | (18.98%) | (56.36%) |
| Return on assets | (49.30%) | (17.64%) | (48.04%) |
| Return on invested capital | 0.00% | (352.49%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack